Drugs Made In America Acquisition (DMII) Income towards Parent Company (2025)
Drugs Made In America Acquisition (DMII) reported Income towards Parent Company of $4.6 million for Q4 2025, up 10041.88% quarter-over-quarter from -$46158.0 in Q3 2025.
Drugs Made In America Acquisition (DMII) Income towards Parent Company (2025) Analysis & Trends
Drugs Made In America Acquisition (DMII) has 1 years of Income towards Parent Company data on file, last reported at $4.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.93 Mn | 477.93 Mn | - |
| 2 | GP-Act III Acquisition | 312.80 Mn | 312.80 Mn | - |
| 3 | Berto Acquisition | 311.56 Mn | 311.56 Mn | - |
| 4 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - |
| 5 | Centurion Acquisition | 310.21 Mn | 310.21 Mn | - |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - |
| 7 | Agriculture & Natural Solutions Acquisition | 303.81 Mn | 303.81 Mn | - |
| 8 | Bold Eagle Acquisition | 274.64 Mn | 274.64 Mn | - |
| 9 | Live Oak Acquisition Corp. V | 265.88 Mn | 265.88 Mn | - |
| 10 | Drugs Made In America Acquisition | 129.34 Mn | 129.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.59 Mn |
| Sep 30, 2025 | -46,158.00 |